Augusto Montezano graduated in Pharmacy and Biochemistry at the Paulista University, Sao Paulo, Brazil in 2001 and completed his PhD (Pharmacology) in 2006, at the University of Sao Paulo, Brazil, under the supervision of Prof Rita Tostes. In 2008, he joined Prof Rhian Touyz at the Kidney Research Centre, Ottawa Hospital Research Institute, Canada, as a post-doctoral fellow, to study the renin-angiotensin-aldosterone system (RAAS), NADPH oxidases and cardiovascular diseases. His work was funded by competitive fellowships from the Canadian Institute of Health Research (CIHR) and the Heart and Stroke Foundation of Canada. As a post-doctoral fellow, he was also successful in securing research funding from Amgen, which allow him to start to develop his work on vascular calcification. In 2012, Dr. Montezano relocated to the Institute of Cardiovascular and Medical Sciences (ICAMS), University of Glasgow, as a Leadership Fellow. In 2018 he became a Walton Fellow in Cardiovascular Medicine at the University of Glasgow. His current research, focuses on osteogenic factors, vascular biology and implications in cardiovascular disease. Over the past few years, Dr. Montezano have also been interested in exploring the vascular effects of SARS-CoV-2 virus and ACE2. This exciting and timely work was funded by the Institutional Strategic Support Funding (ISSF), supported by the Wellcome Trust. Throughout his career, Dr. Montezano’s work has consistently been published in the highest specialty journals, including Circulation Research, Hypertension, ATVB and Clinical Science. His research has been recognized by his peers, nationally and internationally and he has been honored with 30 research awards, including the prestigious Annual High Blood Pressure Research Council New Investigator Award from the Council on Hypertension (AHA). Dr. Montezano is an active member of the hypertension scientific community as Hypertension Social Media Editor and advocating for Early Career Researchers at the executive and mentoring committees of the European Council on Cardiovascular Research, leadership committee of the AHA Council on Hypertension and the mentorship and training committee of the International Society of Hypertension.